Previous Page
32 nanotimes Companies Facts
Oxford Instruments also published preliminary results for the year to 31 March 2012. Highlights: Revenue increased 28.6% to GBP337.3 million; (US$523; 2011: GBP262.3m (US$406m)); Order intake up 23.5% to GBP337.8 million (US$524 million); Record performance across all three business sectors, with strong organic growth in all territories; Three acquisitions made during the year – Omicron Nanotechnology, Omniprobe and Platinum Medical Imaging – all integrating well; Strengthening new product pipeline, with 44% of revenue from products launched or acquired in the last three years (2011: 34%); Proposed final dividend increased by 11.6% to 7.23 pence, giving a total dividend for the year of 10.0 pence (2011: 9.0 pence).
http://www.oxford-instruments.com
Particular GmbH from Hannover, Germany, is cooperating with Strem Chemicals, Inc., from Massachusetts, USA. The German specialist for pure metal nanoparticles is proud to announce that Strem, a renowned distributor of specialty chemicals, are going to start world-wide sales of Particular‘s nanomaterials to customers from all fields of nanotech R&D.
The German company piezosystem jena GmbH presents its piezo-electric nano positioning stage and newly advanced design of the PX 100 CAP. The PX 100 CAP is a part of their well known PX 100 series. Without compromising the excellent accuracy, the travel range has been extended up to 120µm of motion in open loop mode and 100µm of motion in closed loop mode. For positioning control a high resolution capacitive feedback sensor is implemented. The sensor is able to measure a deviation of the accuracy with sub-nm accuracy, and operates in a direct metrology fashion.
pSivida Corp. (NASDAQ: PSDV, ASX: PVA), a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, has been issued US patent No. 8,192,408 titled “Ocular Trocar Assembly” for a new inserter developed to facilitate administration of micro-drug delivery devices. "We are very pleased with the issuance of this US patent for our new inserter," said Dr. Paul Ashton, president and CEO of pSivida.